Narrow trading range before breakout. This is based on the predictive power of the shape of the pennant formation. This combined with time extension Fibonacci portends a breakout this week. Coincidentally there's also an upcoming conference. Cause or effect -take your pick.
What is the power of the study? We're talking about a profound treatment effect here. N doesn't have to be that big to reject the null hypothesis. Concerns about N were reasonable in the early months but as time goes on the treatment effect keeps getting less and less likely due to chance.
I'm long a 300 NFLX put for december. Holding through earnings. Sell-side analysts are FOS. JMHO.
You should avoid negative self-talk. The thought is the father of the action.
Siga is testing resistance again. 4 bucks is a breakout. Close above on 1.5x volume to confirm.
So you paid 2.50 for the contracts, and the current bid is 1.30 and you're down nearly 50%. Now do you see my point? Your strike is too far out of the money to capture much delta. The stock price will have to move below 43 to see a gain. Good luck.
The problem with playing options in biotech is that there' s low liquidity and the long trades are usually overpriced. That's why you are losing money. Taking the other side generally works better. If you are bearish, why not buy the stock and sell calls?
The information supplied to the FDA to get a readout on whether they would accept a surrogate endpoint as the basis of approval constitutes a rolling submission. I think they could submit clinical data now. From what I see the data that's not available yet relates to manufacturing and stability.
I keep making this point: There's no reason to sell out. A license for E is all GSK would need. If RNA got a partnership and went public why would the deal be any different for SRPT? I think irrational exuberance is what keeps this idea alive.
I noticed this morning that the stock was testing strong resistance at 3.75 this week. The next resistance is at 3.90 which seems to be holding. it is rather weak and could easily be taken out with some volume here. Next resistance is the 52 week high at 4.60.. I'd like to see a close at/above the current HOD to confirm the breakout.
There's a history of leaked information coming out of the government on this stock. It's not unusual to see low volume moves ahead of news. There are several government agencies that get inside information on the contracts. It may be that another shipment was made to BARDA. I also think there are hedge funds doing paired algo trading on siga/pip. Siga is trading substantially below the 2:1 price ratio to its Siamese twin (PIP).
80% of outstanding is 26.8 million shares. that leaves only 6.7 million for everyone else to own. There are 12.5 million sold short. So yeah there are none to buy in the real world. The shares being traded don't really even exist.